UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$456M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$403M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$391M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$381M |
| 5 |
UnitedHealth
UNH
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$596M |
| 4 |
Johnson & Johnson
JNJ
|
+$307M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.58% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCD
3751
Calamos Dynamic Convertible & Income Fund
CCD
$745M
| $1.6M | ﹤0.01% |
73,654
+11,801
| +19% | +$263K |
|
3752
Construction Partners
ROAD
$6.86B
| $1.6M | ﹤0.01% |
51,003
+23,820
| +88% | +$682K |
|
3753
Amylyx Pharmaceuticals
AMLX
$2.63B
| $1.6M | ﹤0.01% |
74,075
+27,522
| +59% | +$743K |
|
3754
AMC Global Media
AMCX
$486M
| $1.6M | ﹤0.01% |
133,555
-10,123
| -7% | -$146K |
|
3755
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.97B
| $1.6M | ﹤0.01% |
85,609
-2,864
| -3% | -$53.1K |
|
3756
Independence Realty Trust
IRT
$3.93B
| $1.59M | ﹤0.01% |
87,496
+7,681
| +10% | +$131K |
|
|
AWF
3757
AllianceBernstein Global High Income Fund
AWF
$878M
| $1.59M | ﹤0.01% |
159,642
-16,136
| -9% | -$157K |
|
|
RA
3758
Brookfield Real Assets Income Fund
RA
$706M
| $1.59M | ﹤0.01% |
94,861
-32,621
| -26% | -$546K |
|
3759
First Bancorp
FBP
$4.43B
| $1.59M | ﹤0.01% |
130,059
-11,165
| -8% | -$130K |
|
3760
Bank OZK
OZK
$5.66B
| $1.59M | ﹤0.01% |
39,490
+1,877
| +5% | +$67.3K |
|
3761
GoodRx Holdings
GDRX
$1.3B
| $1.58M | ﹤0.01% |
287,034
-4,149
| -1% | -$22.3K |
|
3762
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$919M
| $1.58M | ﹤0.01% |
152,890
-2,025
| -1% | -$21K |
|
3763
iShares MSCI Global Sustainable Development Goals ETF
SDG
$174M
| $1.58M | ﹤0.01% |
19,990
-1,212
| -6% | -$96.2K |
|
|
DMC
3764
Del Monte Corp
DMC
$1.45B
| $1.58M | ﹤0.01% |
61,437
-17,267
| -22% | -$477K |
|
|
ROIC
3765
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.58M | ﹤0.01% |
116,853
+113,856
| +3,799% | +$1.48M |
|
|
GRX
3766
Gabelli Healthcare & Wellness Trust
GRX
$147M
| $1.58M | ﹤0.01% |
158,384
+1,198
| +0.8% | +$12K |
|
3767
LiveRamp
RAMP
$2.3B
| $1.58M | ﹤0.01% |
55,233
+23,076
| +72% | +$572K |
|
3768
Barclays
BCS
$93.7B
| $1.58M | ﹤0.01% |
200,599
-424,764
| -68% | -$3.29M |
|
3769
Invesco Energy Exploration & Production ETF
PXE
$85.5M
| $1.58M | ﹤0.01% |
56,644
-4,878
| -8% | -$129K |
|
|
SRCL
3770
DELISTED
Stericycle Inc
SRCL
| $1.58M | ﹤0.01% |
33,929
+25,026
| +281% | +$1.1M |
|
3771
Credo Technology Group
CRDO
$46.2B
| $1.57M | ﹤0.01% |
90,685
+38,772
| +75% | +$461K |
|
3772
CALL
Lyft
LYFT
$6.64B
| $1.57M | ﹤0.01% |
163,900
+7,700
| +5% | +$74K |
|
|
EVM
3773
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $1.57M | ﹤0.01% |
176,547
-21,712
| -11% | -$193K |
|
3774
Liberty Energy
LBRT
$3.51B
| $1.57M | ﹤0.01% |
117,450
-32,577
| -22% | -$422K |
|
|
AMAM
3775
CALL
DELISTED
Ambrx Biopharma Inc
AMAM
| $1.57M | ﹤0.01% |
95,400
-103,400
| -52% | -$1.3M |
|
Similar funds
UBS Group's Q2 2023 Portfolio in Review
As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
- UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
- UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
- UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
- UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
- UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.